Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration?Are there income restrictions for lipitor's patient program?Patent expiry trametinib?When did risperdal constas patent expire published article?Is clarinex off patent?
See the DrugPatentWatch profile for Nifedipine
Who are the Nifedipine API manufacturers in India? Several Indian companies manufacture Nifedipine API (Active Pharmaceutical Ingredient). Some of these companies are: * Aarti Drugs Limited, with multiple manufacturing facilities across India * Hikal Limited, an Indian developer and manufacturer of APIs and intermediates * Ind-Swift Laboratories Limited, an Indian pharmaceutical company with API manufacturing capabilities * Lupin Limited, a leading Indian pharmaceutical company with a strong focus on API manufacturing * Shilpa Medicare Limited, an Indian pharmaceutical company with API manufacturing capabilities It is crucial for pharmaceutical manufacturers and users to verify the quality and regulatory compliance of API manufacturers through regular audits and third-party certifications such as ISO standards or US FDA inspections [1]. What is the current global demand for Nifedipine API? According to the Indian Pharmaceutical Industry Analysis 2020 report, the global demand for Nifedipine API is significant, driven mainly by the growing demand for blood pressure management and cardiovascular disease treatments in developed countries [2]. How does the Nifedipine patent landscape look? Nifedipine's patent landscape varies globally, with patents issued in multiple countries. The Indian Patent Office (IPO) granted a patent for Nifedipine in 1994, which will expire in 2026. However, other countries, such as the United States and Australia, have similar patent filings and grant periods [3]. Are there any regulatory differences for Nifedipine API manufacture in India versus other countries? Yes, the regulatory requirements for Nifedipine API manufacture differ across countries. In India, the companies must comply with the Good Manufacturing Practice (GMP) regulations set by the Central Drugs Standard Control Organisation (CDSCO) [4]. In contrast, companies in the United States must comply with the cGMP regulations set by the FDA. Source: [1] DrugPatentWatch.com (https://www.drugpatentwatch.com/) [2] Indian Pharmaceutical Industry Analysis 2020 report (https://www.ibef.org/industry/pharmaceutical-sector) [3] United States Patent and Trademark Office (USTPO); Australian Patent Office (APO) [4] Central Drugs Standard Control Organisation (CDSCO) (https://cdsco.gov.in/)
Other Questions About Nifedipine :